Investment
Features
FeesSafety
Academy
More
Pluang+

Guggenheim Strategic Opportunities Fund hits rare near 10% discount, halting share issuance amid distribution concerns

Market News
18 Sep 2026
Seeking Alpha
View Source
Bearish
Guggenheim Strategic Opportunities Fund hits rare near 10% discount, halting share issuance amid distribution concerns

Guggenheim Strategic Opportunities Fund (GOF) is now trading at a near double-digit discount, a level not seen since 2016. The fund has halted its at-the-market (ATM) share issuance, which historically helped fund its high 22.7% distribution yield. This pause may signal potential challenges ahead, including possible declines in net asset value (NAV) returns and a distribution cut. While these issues could widen the discount further, they might also present a buying opportunity for investors seeking income.

The Guggenheim Strategic Opportunities Fund (GOF) is noted for its near double-digit discount, a valuation level unseen since 2016. For readers following US stocks on Pluang, here is the market snapshot as of Sep 18, 2026 13:21 WIB: out of 150 priced stocks, 113 rose and 33 fell. Among notable movers, IQ (IQIYI Inc - ADR) gained 4.55% to USD 1.15 with balanced Pluang order activity, Alibaba Group (BABA) rose 3.86% to USD 112.72 despite a majority sell order activity, and Gap Inc (GAP) increased 3.32% to USD 20.84 with a typical hold time of 36 days on Pluang.

More News

Gulfport Energy VP sells 325 shares for $59,400

Gulfport Energy VP sells 325 shares for $59,400

Gulfport Energy's Vice President, Willrath, sold 325 shares of the company's stock, generating $59,400 from the transaction. This insider sale may indicate personal financial decisions or portfolio adjustments but does not necessarily reflect the com...

Market News
Neutral
3 hours ago
Vor Biopharma advances global trials for telitacicept with strong funding and data, eyeing 2027 results.

Vor Biopharma advances global trials for telitacicept with strong funding and data, eyeing 2027 results.

Vor Biopharma is progressing its global Phase 3 trials for telitacicept in treating myasthenia gravis and Sjögren’s syndrome, with full enrollment achieved and topline data expected in the first half of 2027. The company benefits from strong clinical...

Market News
Neutral
4 hours ago
$1M hybrid portfolio can yield $6,000 monthly income with growth and capital protection.

$1M hybrid portfolio can yield $6,000 monthly income with growth and capital protection.

A $1 million hybrid investment portfolio can generate a sustainable monthly income of $6,000 by balancing dividend growth stocks, credit assets, real assets, options, and commodities. This diversified approach aims to provide steady income while prot...

Others
Bullish
4 hours ago
Ethereum's Glamsterdam upgrade launches on Sepolia testnet Oct 6 amid security concerns.

Ethereum's Glamsterdam upgrade launches on Sepolia testnet Oct 6 amid security concerns.

Ethereum plans to activate its major Glamsterdam upgrade on the Sepolia testnet on October 6, 2026, introducing Enshrined Proposer-Builder Separation (ePBS) to increase block capacity and transaction processing time. However, developers have raised s...

Protocol Fundamentals
Neutral
4 hours ago
NEAR Protocol jumps 45% in 3 days on new confidential trading and rewards program

NEAR Protocol jumps 45% in 3 days on new confidential trading and rewards program

NEAR Protocol's token surged 45% from $2.34 to $3.45 within three days, driven by the launch of confidential perpetual trading via Hyperliquid and a new rewards initiative called Push to $3.33. The platform now supports private leveraged trading acro...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App